Centessa Rockets To Three-Year High On $5 Billion Narcolepsy Opportunity
Centessa has a potential blockbuster narcolepsy treatment on its hands, an analyst said Tuesday as the biotech stock surged on test results. The post Centessa Rockets To Three-Year High On $5 Billion Narcolepsy Opportunity appeared first on Investor's Business Daily.
Centessa has a potential blockbuster narcolepsy treatment on its hands, an analyst said Tuesday as the biotech stock surged on test results.
The post Centessa Rockets To Three-Year High On $5 Billion Narcolepsy Opportunity appeared first on Investor's Business Daily.
iShook Opinion
"iShook Opinion" by Beni E Rachmanov, CEO & Founder of iShook. Explore captivating perspectives on entertainment, lifestyle, and sports at ishookdaily.com. Your go-to for engaging insights.
